• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响多发性骨髓瘤荧光杂交荧光激活细胞分选的因素:真实世界经验

Factors Influencing Fluorescence-activated Cell Sorting for Multiple Myeloma Fluorescence Hybridization: Real-world Experience.

作者信息

Choi Jaeguk, Yu Kyunghee, Lee Seung-Tae, Shin Saeam, Choi Jong Rak

机构信息

Department of Laboratory Medicine, Severance Hospital, Seoul, Korea.

Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Ann Lab Med. 2025 May 1;45(3):322-328. doi: 10.3343/alm.2024.0582. Epub 2025 Mar 25.

DOI:10.3343/alm.2024.0582
PMID:40130307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11996684/
Abstract

BACKGROUND

FISH is the standard method for detecting cytogenetic abnormalities (CAs) in patients with multiple myeloma, and pre-enrichment of plasma cells is recommended to increase detection rates. However, optimal strategies to ensure sufficient plasma cell retrieval when standard enrichment techniques fail remain underexplored. We investigated factors influencing the success of fluorescence-activated cell sorting (FACS) and assessed the use of direct FISH in cases in which FACS failed.

METHODS

A retrospective analysis was conducted on 457 bone marrow samples submitted for FISH between November 2016 and May 2022. FACS was considered successful when plasma cells (CD38+ and CD138+ cells) constituted >1% of the total number of cells. Direct FISH was performed for samples with FACS failure.

RESULTS

FACS was successful in 70.9% of cases and had a high positivity rate (94.8%). Shorter sample transfer times significantly improved FACS success, with a 77.1% success rate for transfer times <2 hrs, compared with 67.8% for longer times ( =0.0388). Plasma cell percentage was a strong determinant of FACS success, with a median of 31.2% in successful cases versus 8.5% in failures ( <0.0001). Even when FACS failed, direct FISH detected CAs in 43.6% of cases.

CONCLUSIONS

Plasma cell percentage and sample transfer time are critical factors influencing FACS success. While FACS-FISH demonstrates superior sensitivity in detecting CAs, direct FISH serves as a valuable alternative when FACS fails. These findings highlight the importance of optimizing sample handling and FISH protocols for accurate cytogenetic analysis of multiple myeloma.

摘要

背景

荧光原位杂交(FISH)是检测多发性骨髓瘤患者细胞遗传学异常(CA)的标准方法,建议对浆细胞进行预富集以提高检测率。然而,当标准富集技术失败时,确保充分回收浆细胞的最佳策略仍未得到充分探索。我们研究了影响荧光激活细胞分选(FACS)成功的因素,并评估了在FACS失败的病例中直接进行FISH的应用。

方法

对2016年11月至2022年5月期间提交进行FISH检测的457份骨髓样本进行回顾性分析。当浆细胞(CD38 +和CD138 +细胞)占细胞总数的>1%时,FACS被认为成功。对FACS失败的样本进行直接FISH检测。

结果

FACS在70.9%的病例中成功,阳性率较高(94.8%)。较短的样本转移时间显著提高了FACS的成功率,转移时间<2小时的成功率为77.1%,而较长时间的成功率为67.8%(P = 0.0388)。浆细胞百分比是FACS成功的重要决定因素,成功病例的中位数为31.2%,失败病例为8.5%(P < 0.0001)。即使FACS失败,直接FISH在43.6%的病例中检测到了CA。

结论

浆细胞百分比和样本转移时间是影响FACS成功的关键因素。虽然FACS-FISH在检测CA方面显示出更高的灵敏度,但当FACS失败时,直接FISH是一种有价值的替代方法。这些发现强调了优化样本处理和FISH方案以进行多发性骨髓瘤准确细胞遗传学分析的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c34/11996684/f4365f1f9cce/alm-45-3-322-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c34/11996684/ead20199ecbe/alm-45-3-322-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c34/11996684/f4365f1f9cce/alm-45-3-322-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c34/11996684/ead20199ecbe/alm-45-3-322-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c34/11996684/f4365f1f9cce/alm-45-3-322-f2.jpg

相似文献

1
Factors Influencing Fluorescence-activated Cell Sorting for Multiple Myeloma Fluorescence Hybridization: Real-world Experience.影响多发性骨髓瘤荧光杂交荧光激活细胞分选的因素:真实世界经验
Ann Lab Med. 2025 May 1;45(3):322-328. doi: 10.3343/alm.2024.0582. Epub 2025 Mar 25.
2
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.荧光原位杂交的细胞遗传学检测通过多发性骨髓瘤中的浆细胞分选得到改善。
Sci Rep. 2022 May 18;12(1):8287. doi: 10.1038/s41598-022-11676-w.
3
[Application of CD138 Immunomagnetic Bead Sorting Combined with Fluorescence in Situ Hybridization in Multiple Myeloma].CD138免疫磁珠分选联合荧光原位杂交在多发性骨髓瘤中的应用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1496-1500. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.029.
4
Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.采用间期荧光原位杂交技术研究多发性骨髓瘤患者的分子细胞遗传学畸变。
Exp Oncol. 2007 Jun;29(2):116-20.
5
Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma.应用免疫磁珠细胞分选法分离多发性骨髓瘤 CD138 阳性浆细胞进行 FISH 分析。
Int J Lab Hematol. 2012 Oct;34(5):541-6. doi: 10.1111/j.1751-553X.2012.01433.x. Epub 2012 Jun 1.
6
Superior detection rate of plasma cell FISH using FACS-FISH.使用流式细胞术荧光原位杂交(FACS-FISH)可提高浆细胞 FISH 的检测率。
Am J Clin Pathol. 2024 Jan 4;161(1):60-70. doi: 10.1093/ajcp/aqad108.
7
Imaging flow cytometric detection of del(17p) in bone marrow and circulating plasma cells in multiple myeloma.应用流式细胞术检测多发性骨髓瘤骨髓和循环浆细胞中 del(17p)。
Int J Lab Hematol. 2024 Jun;46(3):495-502. doi: 10.1111/ijlh.14248. Epub 2024 Feb 21.
8
The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells.应用非常规浆细胞来源可提高浆细胞疾病间期荧光原位杂交的成功率。
Int J Lab Hematol. 2022 Feb;44(1):157-162. doi: 10.1111/ijlh.13731. Epub 2021 Oct 11.
9
[Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].CD138免疫磁珠分选骨髓瘤细胞联合荧光原位杂交技术在检测多发性骨髓瘤细胞遗传学异常中的应用
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun;25(3):807-812. doi: 10.7534/j.issn.1009-2137.2017.03.031.
10
Detection of genomic abnormalities in multiple myeloma: the application of FISH analysis in combination with various plasma cell enrichment techniques.多发性骨髓瘤中基因组异常的检测:FISH 分析联合各种浆细胞富集技术的应用。
Am J Clin Pathol. 2011 Nov;136(5):712-20. doi: 10.1309/AJCPF7NFLW8UAJEP.

本文引用的文献

1
Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases.循环肿瘤DNA在多发性骨髓瘤及其前驱疾病中的临床意义
Ann Lab Med. 2025 May 1;45(3):279-290. doi: 10.3343/alm.2024.0424. Epub 2025 Feb 28.
2
Current Status of Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasms in Korea.韩国血液淋巴肿瘤流式细胞免疫表型分析的现状。
Ann Lab Med. 2024 May 1;44(3):222-234. doi: 10.3343/alm.2023.0298. Epub 2023 Dec 26.
3
Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma.
荧光原位杂交的细胞遗传学检测通过多发性骨髓瘤中的浆细胞分选得到改善。
Sci Rep. 2022 May 18;12(1):8287. doi: 10.1038/s41598-022-11676-w.
4
Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma.基于新一代流式技术的微小残留病灶检测在多发性骨髓瘤患者中的临床应用
Ann Lab Med. 2022 Sep 1;42(5):558-565. doi: 10.3343/alm.2022.42.5.558.
5
Diagnosis and Management of Multiple Myeloma: A Review.多发性骨髓瘤的诊断与治疗:综述
JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003.
6
Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications.多发性骨髓瘤中的遗传异常:预后和治疗意义。
Cells. 2021 Feb 5;10(2):336. doi: 10.3390/cells10020336.
7
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.多发性骨髓瘤中的细胞遗传学异常:与疾病特征和治疗反应的关联。
Blood Cancer J. 2020 Aug 11;10(8):82. doi: 10.1038/s41408-020-00348-5.
8
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management.多发性骨髓瘤:2020 年诊断、风险分层和治疗更新。
Am J Hematol. 2020 May;95(5):548-567. doi: 10.1002/ajh.25791.
9
A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration.多发性骨髓瘤肿瘤异质性和进化的研究进展:病理学、影像学、分子遗传学和临床综合分析。
Virchows Arch. 2020 Mar;476(3):337-351. doi: 10.1007/s00428-019-02725-3. Epub 2019 Dec 17.
10
Recent advances in cytogenetic characterization of multiple myeloma.多发性骨髓瘤细胞遗传学特征的最新进展。
Int J Lab Hematol. 2019 Feb;41(1):5-14. doi: 10.1111/ijlh.12882. Epub 2018 Jul 3.